반응 #4277

ord-554210ee51bc42a99644559814429e25

반응 방정식

CN1CCOCC1
N-methylmorpholine
CN1c2ccccc2C(c2ccccc2F)=NCC1CN
1-methyl-2-aminomethyl-5-(2'-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine
CC(C)COC(=O)Cl
isobutyl chloroformate
CC(C)COC(=O)NCC1CN=C(c2ccccc2F)c2ccccc2N1C
oil
수율 68.2%
CC(C)COC(=O)NCC1CN=C(c2ccccc2F)c2ccccc2N1C
1-methyl-2-[(2-methylpropoxy)carbonyl]aminomethyl-5-(2'-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine
수율 68.2%

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    workup.ADDITIONwas added to the mixture
  2. 2
    기타The resulting reaction mixture
  3. 3
    세척after dilution and washing

실험 절차

According to the method of Example 1, 1-methyl-2-aminomethyl-5-(2'-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine (250 mg, 0.88 mmole) and isobutyl chloroformate (114 μl, 0.88 mmole) were combined with 4 ml of dry methylene chloride, and 97 μl of N-methylmorpholine (0.88 mmole) at -5° C. was added to the mixture. The resulting reaction mixture was allowed to warm to room temperature over 2 hours, and after dilution and washing, rotoevaporation of the dried extracts of the reaction afforded 230 mg of an oil which was purified by silica gel chromatography (ethyl acetate-hexane elution, 7:3 v/v) to give the analytical sample (120 mg) which was 98% pure by HPLC.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US04724237uspto-grants-1988_02